Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer

被引:37
作者
Gupta, Shilpi [1 ]
Kumar, Prabhat [1 ,2 ]
Kaur, Harsimrut [1 ]
Sharma, Nishi [3 ]
Saluja, Daman [1 ]
Bharti, Alok C. [4 ]
Das, Bhudev C. [1 ,2 ]
机构
[1] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res ACBR, Dept Mol Oncol, New Delhi 110007, India
[2] Amity Univ Campus, Amity Inst Mol Med & Stem Cell Res, Sect 125, Noida 201313, Uttar Pradesh, India
[3] Dr Ram Manohar Lohia RML Hosp, Post Grad Inst Med Educ & Res, Dept Otorhinolaryngol, New Delhi 110010, India
[4] Inst Cytol & Prevent Oncol ICMR, Div Mol Oncol, Noida 201301, Uttar Pradesh, India
关键词
SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS INFECTION; TRANSCRIPTION FACTOR AP-1; BREAST-CANCER; ACTIVATOR PROTEIN-1; HEAD; EXPRESSION; PREVALENCE; FAMILY; FOS;
D O I
10.1038/srep16811
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tongue squamous cell carcinoma (TSCC) is most aggressive head and neck cancer often associated with HR-HPV infection. The role of AP-1 which is an essential regulator of HPV oncogene expression and tumorigenesis is not reported in tongue cancer. One hundred tongue tissue biopsies comprising precancer, cancer and adjacent controls including two tongue cancer cell lines were employed to study the role of HPV infection and AP-1 family proteins. An exclusive prevalence (28%) of HR-HPV type 16 was observed mainly in well differentiated tongue carcinomas (78.5%). A higher expression and DNA binding activity of AP-1 was observed in tongue tumors and cancer cell lines with c-Fos and Fra-2 as the major binding partners forming the functional AP-1 complex but c-Jun participated only in HPV negative and poorly differentiated carcinoma. Knocking down of Fra-2 responsible for aggressive tongue tumorigenesis led to significant reduction in c-Fos, c-Jun, MMP-9 and HPVE6/E7 expression but Fra-1 and p53 were upregulated. The binding and expression of c-Fos/Fra-2 increased as a function of severity of tongue lesions, yet selective participation of c-Jun appears to promote poor differentiation and aggressive tumorigenesis only in HPV negative cases while HPV infection leads to well differentiation and better prognosis preferably in nonsmokers.
引用
收藏
页数:15
相关论文
共 63 条
[1]   Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter [J].
Agarwal, SK ;
Novotny, EA ;
Crabtree, JS ;
Weitzman, JB ;
Yaniv, M ;
Burns, AL ;
Chandrasekharappa, SC ;
Collins, FS ;
Spiegel, AM ;
Marx, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) :10770-10775
[2]   THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[3]   HUMAN PAPILLOMAVIRUSES IN 91 ORAL CANCERS FROM INDIAN BETEL QUID CHEWERS - HIGH PREVALENCE AND MULTIPLICITY OF INFECTIONS [J].
BALARAM, P ;
NALINAKUMARI, KR ;
ABRAHAM, E ;
BALAN, A ;
HAREENDRAN, NK ;
BERNARD, HU ;
CHAN, SY .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (04) :450-454
[4]   Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo [J].
Battista, S ;
de Nigris, F ;
Fedele, M ;
Chiappetta, G ;
Scala, S ;
Vallone, D ;
Pierantoni, GM ;
Megar, T ;
Santoro, M ;
Viglietto, G ;
Verde, P ;
Fusco, A .
ONCOGENE, 1998, 17 (03) :377-385
[5]   FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells [J].
Belguise, K ;
Kersual, N ;
Galtier, F ;
Chalbos, D .
ONCOGENE, 2005, 24 (08) :1434-1444
[6]   Head and neck tumor sites differ in prevalence, and spectrum of p53 alterations but these have limited prognostic value [J].
Bosch, FX ;
Ritter, D ;
Enders, C ;
Flechtenmacher, C ;
Abel, U ;
Dietz, A ;
Hergenhahn, M ;
Weidauer, H .
INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (04) :530-538
[7]   TRANSCRIPTIONAL CONTROL OF HUMAN PAPILLOMAVIRUS (HPV) ONCOGENE EXPRESSION - COMPOSITION OF THE HPV TYPE-18 UPSTREAM REGULATORY REGION [J].
BUTZ, K ;
HOPPESEYLER, F .
JOURNAL OF VIROLOGY, 1993, 67 (11) :6476-6486
[8]  
Chen TK, 1996, MOL CARCINOGEN, V15, P215, DOI 10.1002/(SICI)1098-2744(199603)15:3<215::AID-MC7>3.0.CO
[9]  
2-G
[10]  
CRIPE T P, 1990, New Biologist, V2, P450